Search - tctmd.com

Displaying 161 - 180 of 224

Sort: Relevancy | Date

News Conference News TCT 2015

Absorb BVS Matches Xience V in Chinese Patients

Todd Neale

October 12, 2015

News Conference News TCT 2015

BIOSOLVE-II: Novel Absorbable Scaffold Safe, Effective

October 12, 2015

Presentation TCT 2015

I Want to Treat Vulnerable Plaques: Not Today but Tomorrow (From PROSPECT to PROSPECT ABSORB)

Presenter: Gary S. Mintz, Seung-Jung Park, Gregg W. Stone

October 11, 2015

Presentation TCT 2015

Rationale for and Design of HORIZONS-ABSORB

Presenter: Dariusz Dudek, Robert J. de Winter, Gregg W. Stone

October 11, 2015

Presentation TCT 2015

BRS Results to Date: Imaging, Randomized Trials, and Anticipation of ABSORB III

Presenter: Thomas H. Maloney, David G. Rizik

October 11, 2015

Presentation TCT 2015

France Presents: French Absorb Registry Indications and In-Hospital Results

Presenter: George D. Dangas, Eric Van Belle, René Koning

October 11, 2015

News Conference News TCT 2015

Novel Devices Present New Treatment Options for STEMI

Yael L. Maxwell

October 11, 2015

News Conference News TCT 2014

EVERBIO II: Angiographic Outcomes Similar for BVS, EES, BES

September 17, 2014

Presentation TCT 2014

Absorb III/IV: Testing Noninferiority and Superiority

Presenter: Mitchell W. Krucoff, John A. Ormiston, Robert-Jan van Geuns, Dean J. Kereiakes

September 16, 2014

Presentation TCT 2014

Absorb III/IV: Angina and Ischemia Hypotheses

Presenter: Mitchell W. Krucoff, John A. Ormiston, Robert-Jan van Geuns, Gregg W. Stone

September 16, 2014

Presentation TCT 2014

Update: The EXTEND Real-World Registry

Presenter: Mitchell W. Krucoff, John A. Ormiston, Robert-Jan van Geuns, Alexandre Abizaid

September 16, 2014

Presentation TCT 2014

Update: The Absorb ASSURE Real-World Registry

Presenter: Mitchell W. Krucoff, John A. Ormiston, Robert-Jan van Geuns, Thomas Schmitz

September 16, 2014

Presentation TCT 2014

Update: The Absorb GHOST Real-World Registry

Presenter: Mitchell W. Krucoff, John A. Ormiston, Robert-Jan van Geuns, Corrado Tamburino

September 16, 2014

Presentation TCT 2014

Update: The Absorb FIRST Real-World Registry

Presenter: Mitchell W. Krucoff, John A. Ormiston, Robert-Jan van Geuns, Christoph K. Naber

September 16, 2014

Presentation TCT 2014

Update: The Absorb EXPAND Real-World Registry

Presenter: Mitchell W. Krucoff, John A. Ormiston, Robert-Jan van Geuns

September 16, 2014

Presentation TCT 2014

Featured Lecture: ABSORB II: What Has the Randomized Trial Taught us Beyond the Registries?

Presenter: Mitchell W. Krucoff, John A. Ormiston, Robert-Jan van Geuns, Patrick W. Serruys

September 16, 2014

Presentation TCT 2014

Diabetic patients treated with Bioresorbable Vascular Scaffolds show good clinical outcomes at two-year follow-up: A pooled analysis from the ABSORB and SPIRIT trials

Presenter: Javaid Iqbal

September 16, 2014

Presentation TCT 2014

Analysis of Quality of Life Decrements Associated with Changes in Angina Status in the ABSORB II Trial: First Randomized Comparison Between the Absorb? Everolimus Eluting___

Presenter: Bernard Chevalier

September 16, 2014

Presentation TCT 2014

Three Year Clinical Outcomes of a Unique Sirolimus-Eluting Stent with Fully Absorbable Polymer Coating: Long-term Results from the DESSOLVE I and the DESSOLVE II Clinical Trials_

Presenter: John Ormiston

September 16, 2014

Presentation TCT 2014

ABSORB Cohort B Trial: Five Year Angiographic Results Of The ABSORB Everolimus Eluting Bioresorbable Vascular Scaffold_

Presenter: Bernard De Bruyne

September 16, 2014

Advertisement

Absorb BVS Matches Xience V in Chinese Patients

BIOSOLVE-II: Novel Absorbable Scaffold Safe, Effective

I Want to Treat Vulnerable Plaques: Not Today but Tomorrow (From PROSPECT to PROSPECT ABSORB)

Rationale for and Design of HORIZONS-ABSORB

BRS Results to Date: Imaging, Randomized Trials, and Anticipation of ABSORB III

France Presents: French Absorb Registry Indications and In-Hospital Results

Novel Devices Present New Treatment Options for STEMI

EVERBIO II: Angiographic Outcomes Similar for BVS, EES, BES

Absorb III/IV: Testing Noninferiority and Superiority

Absorb III/IV: Angina and Ischemia Hypotheses

Update: The EXTEND Real-World Registry

Update: The Absorb ASSURE Real-World Registry

Update: The Absorb GHOST Real-World Registry

Update: The Absorb FIRST Real-World Registry

Update: The Absorb EXPAND Real-World Registry

Featured Lecture: ABSORB II: What Has the Randomized Trial Taught us Beyond the Registries?

Diabetic patients treated with Bioresorbable Vascular Scaffolds show good clinical outcomes at two-year follow-up: A pooled analysis from the ABSORB and SPIRIT trials

Analysis of Quality of Life Decrements Associated with Changes in Angina Status in the ABSORB II Trial: First Randomized Comparison Between the Absorb? Everolimus Eluting___

Three Year Clinical Outcomes of a Unique Sirolimus-Eluting Stent with Fully Absorbable Polymer Coating: Long-term Results from the DESSOLVE I and the DESSOLVE II Clinical Trials_

ABSORB Cohort B Trial: Five Year Angiographic Results Of The ABSORB Everolimus Eluting Bioresorbable Vascular Scaffold_

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content